Clinical aspects of leprosy

Clinics in Dermatology

Volumn 33, Issue 1, 2015, Pages 26-37

  Talhari, Carolina ^a,b   Talhari, Sinésio ^c   Penna, Gerson Oliveira ^d  

^a Fundacao Alfredo da Matta   (Brazil)

^b UNIVERSIDADE DO ESTADO DO AMAZONAS   (Brazil)

^c UNIVERSIDADE NILTON LINS   (Brazil)

^d UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BACTERIAL LOAD; BORDERLINE LEPROMATOUS LEPROSY; BORDERLINE LEPROSY; BORDERLINE TUBERCULOID LEPROSY; CELLULAR IMMUNITY; CLINICAL FEATURE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; FACIAL NERVE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; HYPOPIGMENTATION; LEPROMATOUS LEPROSY; LEPROSY; MEDIAN NERVE; MIXED INFECTION; MYCOBACTERIUM LEPRAE; NERVE INJURY; NEURITIS; NOTE; PAPULE; PERIPHERAL NEUROPATHY; PERONEUS NERVE; POSTERIOR TIBIAL NERVE; PRIORITY JOURNAL; PURE NEURAL LEPROSY; RADIAL NERVE; SKIN BIOPSY; SKIN DEFECT; SKIN SENSATION; THERMAL STIMULATION; TUBERCULOID LEPROSY; ULNAR NERVE;

EID: 84964300257     PISSN: 0738081X     EISSN: 18791131     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2014.07.002     Document Type: Note

References (68)

1. Britton W.J., Lockwood D.N. Leprosy. Lancet 2004, 363:1209-1219.
2. Ridley D.S., Jopling W.H. A classification of leprosy for research purposes. Lepr Rev 1962, 33:119-128.
3. Ridley D.S., Jopling W.H. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis 1966, 34:255-273.
4. Pereira Júnior A.C., Gurfinkel A.C. Positioning of borderline and indetermined groups in the hanseniasis classification. Hansenol Int 1981, 6:63-70.
5. Lockwood D.N., Sarno E., Smith W.C. Classifying leprosy patients-searching for the perfect solution?. Lepr Rev 2007, 78:317-320.
6. Talhari S. Bangkok Workshop on Leprosy Research. Diagnosis, classification and prognosis. Int J Lepr Other Mycobact Dis 1996, 64:S13-S14. [discussion S14-15].
7. WHO Chemotherapy of leprosy for control programmes. Technical report series 675 1982, World Health Organization, Geneva, [Available from: http://whqlibdoc.who.int/trs/WHO_TRS_675.pdf].
8. WHO A guide to leprosy control 1988, [Geneva. Available from: http://whqlibdoc.who.int/publications/1988/9241542233_(part1).pdf]. 2nd ed.
9. Parkash O. Classification of leprosy into multibacillary and paucibacillary groups: an analysis. FEMS Immunol Med Microbiol 2009, 55:1-5.
10. Pfaltzgraff R.E., Bryceson A.D.M A Clinical leprosy. Leprosy 1985, 134-176. Churchill Livingstone, Edinburgh. R.C. Hastings (Ed.).
11. Languillon J. Skin lesions in leprosy. Clinical aspects. Med Trop (Mars) 1965, 25:573-576.
12. Walker S.L., Lockwood D.N. Leprosy. Clin Dermatol 2007, 25:165-172.
13. Pereira Junior A.C., Do Nascimento L.V. Indeterminate Hansen's disease. Med Cutan Ibero Lat Am 1982, 10:159-164.
14. Sehgal V.N., Srivastava G. Indeterminate leprosy. A passing phase in the evolution of leprosy. Lepr Rev 1987, 58:291-299.
15. Giridhar M., Arora G., Lajpal K., Singh Chahal K. Clinicohistopathological concordance in leprosy - a clinical, histopathological and bacteriological study of 100 cases. Indian J Lepr 2012, 84:217-225.
16. Schaller K.F. Differential diagnosis of leprosy. Int J Lepr Other Mycobact Dis 1971, 39:447-455.
17. Mahé A. Leprosy differential diagnosis in 1996. Acta Leprol 1996, 10:69-77.
18. Nunzi E., Noto S. Observing the skin: papules and nodules in leprosy. Lepr Rev 2008, 79:118.
19. Languillon J. Clinical and developmental aspects of tuberculoid leprosy. Acta Leprol 1986, 4:197-199.
20. Cortés S.L., Rodríguez G. Leprosy in children: association between clinical and pathological aspects. J Trop Pediatr 2004, 50:12-15.
21. Bechelli L.M., Pagnano P.M. Reflections on some aspects of leprosy among children in Brazil and in other countries. Acta Leprol 1990, 7:229-237.
22. Sehgal V.N., Joginder Slit-skin smear in leprosy. Int J Dermatol 1990, 29:9-16.
23. Ramos-e-Silva M., Rebello P.F. Leprosy. Recognition and treatment. Am J Clin Dermatol 2001, 2:203-211.
24. Sehgal V.N. Reactions in leprosy. Clinical aspects. Int J Dermatol 1987, 26:278-285.
25. Rollier R., Rollier B. Clinical and developmental aspects of lepromatous leprosy. Acta Leprol 1986, 4:193-195.
26. Wade H.W. The histoid variety of lepromatous leprosy. Int J Lepr 1963, 31:129-142.
27. Nair S.P., Nanda Kumar G. A clinical and histopathological study of histoid leprosy. Int J Dermatol 2013, 52:580-586.
28. Latapi F., Chévez-Zamora A. The "spotted" leprosy of Lucio: an introduction to its clinical and histological study. Int J Lepr 1948, 16:421-437.
29. Latapi F. Diffuse lepromatosis; clinical & histopathological aspects [article in Spanish]. Minerva Dermatol 1959, 34:272-278.
30. Magaña M., Fernández-Díez J., Magaña M.L. Lucio's phenomenon is a necrotizing panvasculitis: mostly a medium-sized granulomatous arteritis. Am J Dermatopathol 2008, 30:555-560.
31. Azulay-Abulafia L., Pereira Spinelli L., et al. Lucio phenomenon. Vasculitis or occlusive vasculopathy?. Hautarzt 2006, 57:1101-1105.
32. Han X.Y., Seo Y.H., Sizer K.C., et al. A new Mycobacterium species causing diffuse lepromatous leprosy. Am J Clin Pathol 2008, 130:856-864.
33. Brazin S.A. Leprosy (Hansen's disease). Otolaryngol Clin North Am 1982, 15:597-611.
34. Pollack J.D., Pincus R.L., Lucente F.E. Leprosy of the head and neck. Otolaryngol Head Neck Surg 1987, 97:93-96.
35. Malik A.N., Morris R.W., Ffytche T.J. The prevalence of ocular complications in leprosy patients seen in the United Kingdom over a period of 21years. Eye (Lond) 2011, 25:740-745.
36. Samanta S.K., Das D. Recent advances in ocular leprosy. Indian J Lepr 2007, 79:135-150.
37. Bernard J.C., Vazquez C.A. Visceral lesions in lepromatous leprosy. Study of sixty necropsies. Int J Lepr Other Mycobact Dis 1973, 41:94-101.
38. Nigam P., Mukhija R.D., Kapoor K.K., et al. Male gonads in leprosy-a clinico-pathological study. Indian J Lepr 1988, 60:77-183.
39. Nigam P., Mukhija R.D., Gupta A.K., Dayal S.G., Goyal B.M. Gonadal involvement in leprosy-study of gynaecomastia, testicular and epididymal involvement and therapeutic efficacy of indigenous drugs. Hansenol Int 1984, 9:10-20.
40. Moonot P., Ashwood N., Lockwood D. Orthopaedic complications of leprosy. J Bone Joint Surg (Br) 2005, 87:1328-1332.
41. Gabino J.A., Naafs B. Primary neural leprosy. Leprosy: A practical guide 2012, Springer Verlag, Italia. E. Nunzi, C. Massone (Eds.).
42. Uplekar M.W., Antia N.H. Clinical and histopathological observations on pure neuritic leprosy. Indian J Lepr 1986, 58:513-521.
43. Flageul B. Diagnosis and treatment of leprous neuropathy in practice. Rev Neurol (Paris) 2012, 168:960-966.
44. Ramachandran A., Neelan P.N. Autonomic neuropathy in leprosy. Indian J Lepr 1987, 59:405-413.
45. Grimaud J. Peripheral nerve damage in patients with leprosy. Rev Neurol (Paris) 2012, 168:967-974.
46. Iwata M. Clinical aspects of leprous neuropathy. Brain Nerve 2011, 63:157-164.
47. Van Brakel W.H. Peripheral neuropathy in leprosy and its consequences. Lepr Rev 2000, 71:S146-S153. [Suppl].
48. Joint United Nations Programme on HIV/AIDS (UNAIDS) [Internet]. UNAIDS Report on the global AIDS epidemic 2012, [Available from: http://www.unaids.org/en/resources/publications/2012/name,76121,en.asp].
49. Ustianowski A.P., Lawn S.D., Lockwood D.N.J. Interactions between HIV infection and leprosy: a paradox. Lancet Infect Dis 2006, 6:350-360.
50. Massone C., Talhari C., Ribeiro-Rodrigues R., et al. Leprosy and HIV coinfection: a critical approach. Expert Rev Anti Infect Ther 2011, 9:701-710.
51. Sekar B., Jayasheela M., Chattopadhya D., et al. Prevalence of HIV infection and high-risk characteristics among leprosy patients of south India; a case-control study. Int J Lepr Other Mycobact Dis 1994, 62:527-531.
52. Andrade V.L., Moreira A.T., Avelleira J.C. Prevalence of HIV-1 in leprosy patients in Rio de Janeiro, Brazil. Acta Leprol 1997, 10:159-163.
53. Machado P., David Y., Pedroso C., Brites C., Barral A., Barral-Netto M. Leprosy and HIV infection in Bahia, Brazil. Int J Lepr Other Mycobact Dis 1998, 3:227-229.
54. Leonard G., Sangare A., Verdier M. Prevalence of HIV infection among patients with leprosy in African countries and Yemen. J Acquir Immune Defic Syndr 1990, 3:1109-1113.
55. Meeran K. Prevalence of HIV infection among patients with leprosy and tuberculosis in rural Zambia. BMJ 1989, 298:364-365.
56. Ponnighaus J.M., Mwanjasi L.J., Fine P.E. Is HIV infection a risk factor for leprosy?. Int J Lepr Other Mycobact Dis 1991, 59:221-228.
57. Frommel D., Tekle-Haimanot R., Verdier M., Negesse Y., Bulto T., Denis F. HIV infection and leprosy: a four-year survey in Ethiopia. Lancet 1994, 344:165-166.
58. Talhari C., Mira M.T., Massone C., et al. Leprosy and HIV coinfection: a clinical, pathological, immunological, and therapeutic study of a cohort from a Brazilian referral center for infectious diseases. J Infect Dis 2010, 202:345-354.
59. Lawn S.D., Wood C., Lockwood D.N. Borderline tuberculoid leprosy: an immune reconstitution phenomenon in a human immunodeficiency virus-infected person. Clin Infect Dis 2003, 36:e5-e6.
60. Talhari C., Machado P.R., Ferreira L.C., Talhari S. Shifting of the clinical spectrum of leprosy in an HIV-positive patient: a manifestation of immune reconstitution inflammatory syndrome?. Lepr Rev 2007, 78:151-154.
61. Pignataro P., Rocha Ada S., Nery J.A. Leprosy and AIDS: two cases of increasing inflammatory reactions at the start of highly active antiretroviral therapy. Eur J Clin Microbiol Infect Dis 2004, 23:408-411.
62. Couppiei P., Abel S., Voinchet H. Immune reconstitution inflammatory syndrome associated with HIV and leprosy. Arch Dermatol 2004, 140:997-1000.
63. Talhari C., Matsuo C., Chrusciak-Talhari A., de-Lima-Ferreira L.C., Mira M., Talhari S. Variations in leprosy manifestations among HIV-positive patients, Manaus, Brazil. Emerg Infect Dis 2009, 15:673-674.
64. Deps P., Lucas S., Porro A.M., Maeda S.M. Clinical and histological features of leprosy and human immunodeficiency virus co-infection in Brazil. Clin Exp Dermatol 2013, 38:470-477.
65. Penna M.L., Buhrer-Sékula S., Pontes M.A., Cruz R., Gonçalves H.D., Penna G.O. Primary results of clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): reactions frequency in multibacillary patients. Lepr Rev 2012, 83:308-309.
66. Gelber R.H., Grosset J. The chemotherapy of leprosy: An interpretive history Editorial. Lepr Rev 2012, 83:221-240.
67. WHO Expert Committee on leprosy: eighth report. (WHO technical report series; no. 968) World Health Organization. II 2010, WHO Expert Committee on Leprosy, Geneva, Switzerland, [Available from: http://apps.who.int/iris/bitstream/10665/75151/1/WHO_TRS_968_eng.pdf].
68. Penna M.L., Temporão J.G., Grossi M.A., Penna G.O. Leprosy control: knowledge shall not be neglected. J Epidemiol Community Health 2011, 65:473-474.